fig10

IL-32 as a prognostic biomarker and therapeutic target in glioma: implications for tumor progression and immune modulation

Figure 10. Identification of potentially effective drugs for high-risk glioma patients. (A) Lollipop plots illustrate the Pearson correlation coefficients between the risk score and IC50 values of various drugs across three independent glioma cohorts; (B) A Venn diagram identifies six drugs that are more likely to be effective in high-risk glioma patients, as they consistently demonstrated significant correlations with the risk score across all three cohorts. IC50: Half-Maximal Inhibitory Concentration; TCGA: The Cancer Genome Atlas; CGGA: Chinese Glioma Genome Atlas.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/